Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03134833 · ClinicalTrials.gov registry record · NA
Engaging Seronegative Youth to Optimize HIV Prevention Continuum
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 1,478
- Enrollment target
NCT03134833: Completed NA study, sponsored by University of California, Los Angeles.
NCT03134833 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 1,478 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03134833, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,478 participants
- Enrollment target
Study Summary
The focus of this study (Engaging Seronegative Youth to Optimize HIV Prevention Continuum) - will be to stop HIV-related risk acts and to encourage youth at high risk for HIV to adopt antiretroviral medications as treatment and prevention (either pre exposure prophylaxis (PrEP) or post exposure prophylaxis) among gay, bisexual and transgender and/or homeless youth with contact with the criminal justice system in the HIV epicenters of Los Angeles and New Orleans. A cohort of 1500 youth at the highest risk of seroconverting over 24 months will be identified. The goal will be to optimize the HIV Prevention Continuum over 24 months. The proposed randomized controlled trial (RCT) aims to compare youth outcomes when randomized to one of four automated and person-mediated social media delivered intervention conditions: 1) Automated Messaging and Monitoring Intervention (AMMI) only (n=900) consisting of daily motivational, instructional, and referral text-messaging (SMS), and brief, weekly SMS monitoring surveys of outcomes; 2) Peer Support through social media plus AMMI (n=200) via private online discussion boards; 3) Coaching plus AMMI (n=200) to provide service linkages, eligibility support, appointment coordination and follow-up, communication with healthcare providers, and brief motivational and strengths-based counseling for linkage and retention to prevention, mental health, and substance abuse services; and, 4) Coaching plus Peer Support and AMMI (n=200).
Primary Outcome
Self-reported # of times - lifetime, past 4 months (reported at four-month assessment points)
Interventions
- BEHAVIORAL Peer Support
- BEHAVIORAL Coaching
- BEHAVIORAL Automated Messaging & Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,478 participants |
| Start Date | 2017-05-06 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
What the finished NCT03134833 record still lists
NCT03134833 is an interventional study that assigns participants to a tested intervention. Its 1,478 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Peer Support is the first listed.
NCT03134833 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03134833 about?
NCT03134833 is a clinical study titled "Engaging Seronegative Youth to Optimize HIV Prevention Continuum". The focus of this study (Engaging Seronegative Youth to Optimize HIV Prevention Continuum) - will be to stop HIV-related risk acts and to encourage youth at high risk for HIV to adopt antiretroviral medications as treatment and prevention (either pre exposure prophylaxis (PrEP) or post exposure prop...
What is the current status of trial NCT03134833?
This trial is currently completed. It is a NA study. The enrollment target is 1,478 participants. The study started on 2017-05-06. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT03134833?
The interventions under investigation include: Peer Support (BEHAVIORAL), Coaching (BEHAVIORAL), Automated Messaging & Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT03134833?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03134833's enrollment target sits among peer trials
1,478 68th of 2000 higher than 1,933 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05869552 · 1,485 participants · NA
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI